Pancreatic Cancer Research

ResearcherUniversity of AntwerpActive in the last 2 years

Christophe Deben

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8085-2040; OpenAlex author ID A5081479570. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 7

  1. IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. Co-author DOI 10.1016/j.omton.2026.201316↗
  2. Short cold atmospheric plasma treatment preserves vascular quiescence in 3D tumor-stroma-endothelial models of pancreatic cancer in vitro and in ovo. Co-author DOI 10.1038/s41698-025-01241-9↗
  3. Capturing the Heterogeneity of the PDAC Tumor Microenvironment: Novel Triple Co-Culture Spheroids for Drug Screening and Angiogenic Evaluation. Co-author DOI 10.3390/cells14060450↗
  4. Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by… Co-author DOI 10.1186/s13046-024-03012-z↗
  5. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer. Last author DOI 10.1038/s41698-023-00480-y↗
  6. Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer. Co-author DOI 10.3390/cancers13050987↗
  7. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers11101597↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Evelien Smits · 7 shared papers, 2019–2026 · strength 1.20
  2. Geert Roeyen · 5 shared papers, 2021–2026 · strength 0.89
  3. Hans Prenen · 4 shared papers, 2021–2026 · strength 0.66
  4. Jonas R.M. Van Audenaerde · 4 shared papers, 2019–2026 · strength 0.64
  5. Annemie Bogaerts · 3 shared papers, 2019–2025 · strength 0.55
  6. Marc Peeters · 4 shared papers, 2019–2024 · strength 0.52
  7. Ruben Verloy · 2 shared papers, 2025 · strength 0.47
  8. Angela Privat‐Maldonado · 2 shared papers, 2025 · strength 0.47
  9. Delphine Quatannens · 2 shared papers, 2021–2025 · strength 0.34
  10. Maxim Le Compte · 2 shared papers, 2023–2024 · strength 0.33
  11. Andreas Domen · 2 shared papers, 2021–2023 · strength 0.26
  12. Timon Vandamme · 2 shared papers, 2021–2023 · strength 0.26
  13. Laura Gehrcken · 1 shared paper, 2026 · strength 0.22
  14. Sofía L. J. Peeters · 1 shared paper, 2023 · strength 0.15
  15. Sara R. Zanivan · 1 shared paper, 2021 · strength 0.11
  16. Jinthe Van Loenhout · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.